Cargando…
Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)
BACKGROUND: Survival rates for lymphoma are highest amongst hematological malignancies. In 2019, it was estimated that over 6400 Australians were diagnosed with lymphoma, a group of hematological malignancies with a high 5-year survival rate of ~ 76%. There is an increased focus on the promotion of...
Autores principales: | Chan, Raymond Javan, Buhagiar, Stephanie, Teleni, Laisa, Simonsen, Camilla, Turner, Jane, Rawson, Courtney, Hart, Nicolas H., Jones, Lee, Gordon, Louisa, Joseph, Ria, Agbejule, Oluwaseyifunmi Andi, Henderson, Fiona, Rhee, Joel, Ryan, Marissa, Carrington, Christine, Mapp, Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787240/ https://www.ncbi.nlm.nih.gov/pubmed/33407797 http://dx.doi.org/10.1186/s13063-020-04945-4 |
Ejemplares similares
-
Outcomes of cancer survivorship education and training for primary care providers: a systematic review
por: Chan, Raymond J., et al.
Publicado: (2021) -
Correction to: Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management
por: Agbejule, Oluwaseyifunmi Andi, et al.
Publicado: (2021) -
Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management
por: Agbejule, Oluwaseyifunmi Andi, et al.
Publicado: (2021) -
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial)
por: Chan, Raymond Javan, et al.
Publicado: (2020) -
Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial)
por: Ladwa, Rahul, et al.
Publicado: (2022)